Ischemia Reperfusion Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Ischemic reperfusion injury is the tissue damage that happens when blood supply returns to the tissue after a period of lack of oxygen. The absence of oxygen and nutrients creates a condition in which the restoration of circulation results in inflammation and oxidative damage through the induction of oxidative. Symptoms include headache, bradycardia, seizures, and hypertension. Risk factors include hypertension, hyperlipidemia, diabetes, insulin resistance, heart failure, altered coronary circulation, and aging.
The Ischemia Reperfusion Injury drugs in development market research report provides comprehensive information on the therapeutics under development for Ischemia Reperfusion Injury, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Ischemia Reperfusion Injury and features dormant and discontinued projects.
What are the key targets in the Ischemia Reperfusion Injury pipeline products market?
The key targets in the Ischemia Reperfusion Injury pipeline products market are Protein Kinase C Epsilon Type, Protein Tyrosine Phosphatase, 6 Phosphofructo 2 Kinase/Fructose 2,6 Bisphosphatase 3, Actin, Adenosine A2 Receptor, Adenosine Receptor A1, Adenosine Receptor A2a, Aldehyde Dehydrogenase Mitochondrial, Androgen Receptor, C Reactive Protein, and others.
Ischemia Reperfusion Injury Pipeline Products Analysis Market by Targets
For more target insights, download a free report sample
What are the key mechanisms of action in the Ischemia Reperfusion Injury pipeline products market?
The key mechanisms of action in the Ischemia Reperfusion Injury pipeline products market are Protein Kinase C Epsilon Type Inhibitor, Protein Tyrosine Phosphatase Inhibitor, 6 Phosphofructo 2 Kinase/Fructose 2,6 Bisphosphatase 3 Inhibitor, Actin Inhibitor, Adenosine A2 Receptor Agonist, Adenosine Receptor A1 Agonist, Adenosine Receptor A2a Agonist, Androgen Receptor Antagonist, C Reactive Protein Inhibitor, Calcium/Calmodulin Dependent Protein Kinase Type II Inhibitor, and others.
Ischemia Reperfusion Injury Pipeline Products Market Analysis by Mechanism of Actions
For more mechanism of actions insights, download a free report sample
What are the key routes of administration in the Ischemia Reperfusion Injury pipeline products market?
The key routes of administration in the Ischemia Reperfusion Injury pipeline products market are intravenous, oral, subcutaneous, parenteral, intradermal, intramuscular, intravenous bolus, intravesical, ophthalmic, and topical.
Ischemia Reperfusion Injury Pipeline Products Market Analysis by Routes of Administration
For more routes of administration insights, download a free report sample
What are the different molecule types in the Ischemia Reperfusion Injury pipeline products market?
The different molecule types in the Ischemia Reperfusion Injury pipeline products market are small molecule, recombinant protein, monoclonal antibody, synthetic peptide, fusion protein, peptide, polysaccharide, recombinant peptide, biologic, oligonucleotide, and others.
Ischemia Reperfusion Injury Pipeline Products Market Analysis by Molecule Type
To know more about molecule types, download a free report sample
Which are the major companies in the Ischemia Reperfusion Injury pipeline products market?
Some of the major companies in the Ischemia Reperfusion Injury pipeline products market are Balmes Transplantation SAS, Young Therapeutics LLC, Apollo Therapeutics LLC, CFM Pharma Holding BV, Corline Biomedical AB, Ischemix Inc, Radikal Therapeutics Inc, Revive Therapeutics Ltd, Abfero Pharmaceuticals Inc, and Amyndas Pharmaceuticals LLC.
Ischemia Reperfusion Injury Pipeline Products Market Analysis by Companies
To know more about major companies, download a free report sample
Market Report Scope
| Key targets | Protein Kinase C Epsilon Type, Protein Tyrosine Phosphatase, 6 Phosphofructo 2 Kinase/Fructose 2,6 Bisphosphatase 3; Actin, Adenosine A2 Receptor, Adenosine Receptor A1, Adenosine Receptor A2a, Aldehyde Dehydrogenase Mitochondrial, Androgen Receptor, C Reactive Protein, and Others |
| Key mechanism of action | Protein Kinase C Epsilon Type Inhibitor, Protein Tyrosine Phosphatase Inhibitor, 6 Phosphofructo 2 Kinase/Fructose 2,6 Bisphosphatase 3 Inhibitor; Actin Inhibitor, Adenosine A2 Receptor Agonist, Adenosine Receptor A1 Agonist, Adenosine Receptor A2a Agonist, Androgen Receptor Antagonist, C Reactive Protein Inhibitor, Calcium/Calmodulin Dependent Protein Kinase Type II Inhibitor, and Others |
| Key routes of administration | Intravenous, Oral, Subcutaneous, Parenteral, Intradermal, Intramuscular, Intravenous Bolus, Intravesical, Ophthalmic, and Topical |
| Molecule type | Small Molecule, Recombinant Protein, Monoclonal Antibody, Synthetic Peptide, Fusion Protein, Peptide, Polysaccharide, Recombinant Peptide, Biologic, Oligonucleotide, and Others |
| Major companies | Balmes Transplantation SAS, Young Therapeutics LLC, Apollo Therapeutics LLC, CFM Pharma Holding BV, Corline Biomedical AB, Ischemix Inc, Radikal Therapeutics Inc, Revive Therapeutics Ltd, Abfero Pharmaceuticals Inc, and Amyndas Pharmaceuticals LLC |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Ischemia Reperfusion Injury (Cardiovascular).
- The pipeline guide reviews pipeline therapeutics for Ischemia Reperfusion Injury (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Ischemia Reperfusion Injury (Cardiovascular) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Ischemia Reperfusion Injury (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Ischemia Reperfusion Injury (Cardiovascular)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with a potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Ischemia Reperfusion Injury (Cardiovascular).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Ischemia Reperfusion Injury (Cardiovascular) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
Amyndas Pharmaceuticals LLC
Anagenics Ltd
Apollo Therapeutics LLC
Argenx SE
Asta Pharmaceuticals Co Ltd
Axolo Pharma Inc
Balmes Transplantation SAS
Beijing Northland Biotech Co Ltd
Bolder Biotechnology Inc
Celdara Medical LLC
CFM Pharma Holding BV
Corline Biomedical AB
Curacle Co Ltd
Cypralis Ltd
Domainex Ltd
EVAS Therapeutics LLC
Faron Pharmaceuticals Oy
Gero Discovery
Gilead Sciences Inc
Glucox Biotech AB
Ischemix Inc
Larix Bioscience LLC
Lee's Pharmaceutical Holdings Ltd
LUCA Science Inc
Mallinckrodt Plc
Neuroene Therapeutics LLC
New Beta Innovation Ltd
New Horizons Pharma Inc
Nour Heart Therapeutics LLC
NuNerve Pty Ltd
Orion Corp
Oxitope Pharma BV
Pfizer Inc
Pharming Group NV
Radikal Therapeutics Inc
Reata Pharmaceuticals Inc
Revive Therapeutics Ltd
Sairiyo Therapeutics Inc
SBI Pharmaceuticals Co Ltd
Slate Bio Inc
Stealth BioTherapeutics Corp
TheraSource LLC
United Therapeutics Corp
Young Therapeutics LLC
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Ischemia Reperfusion Injury pipeline products market?
The key targets in the Ischemia Reperfusion Injury pipeline products market are Protein Kinase C Epsilon Type, Protein Tyrosine Phosphatase, 6 Phosphofructo 2 Kinase/Fructose 2,6 Bisphosphatase 3; Actin, Adenosine A2 Receptor, Adenosine Receptor A1, Adenosine Receptor A2a, Aldehyde Dehydrogenase Mitochondrial, Androgen Receptor, C Reactive Protein, and others.
-
What are the key mechanisms of action in the Ischemia Reperfusion Injury pipeline products market?
The key mechanisms of action in the Ischemia Reperfusion Injury pipeline products market are Protein Kinase C Epsilon Type Inhibitor, Protein Tyrosine Phosphatase Inhibitor, 6 Phosphofructo 2 Kinase/Fructose 2,6 Bisphosphatase 3 Inhibitor; Actin Inhibitor, Adenosine A2 Receptor Agonist, Adenosine Receptor A1 Agonist, Adenosine Receptor A2a Agonist, Androgen Receptor Antagonist, C Reactive Protein Inhibitor, Calcium/Calmodulin Dependent Protein Kinase Type II Inhibitor, and others.
-
What are the key routes of administration in the Ischemia Reperfusion Injury pipeline products market?
The key routes of administration in the Ischemia Reperfusion Injury pipeline products market are intravenous, oral, subcutaneous, parenteral, intradermal, intramuscular, intravenous bolus, intravesical, ophthalmic, and topical.
-
What are the different molecule types in the Ischemia Reperfusion Injury pipeline products market?
The different molecule types in the Ischemia Reperfusion Injury pipeline products market are small molecule, recombinant protein, monoclonal antibody, synthetic peptide, fusion protein, peptide, polysaccharide, recombinant peptide, biologic, oligonucleotide, and others.
-
Which are the major companies in the Ischemia Reperfusion Injury pipeline products market?
Some of the major companies in the Ischemia Reperfusion Injury pipeline products market are Balmes Transplantation SAS, Young Therapeutics LLC, Apollo Therapeutics LLC, CFM Pharma Holding BV, Corline Biomedical AB, Ischemix Inc, Radikal Therapeutics Inc, Revive Therapeutics Ltd, Abfero Pharmaceuticals Inc, and Amyndas Pharmaceuticals LLC.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Cardiovascular reports